Boostimmune logo — Developing breakthrough therapies to fight cancer by harness...

Boostimmune

Developing breakthrough therapies to fight cancer by harnessing the power of the immune system through the dedication and expertise of an innovative team.

Founded 2021 Series Unknown Biotechnology, Health Care +1

General Information

Company Name Boostimmune
Founded Year 2021
Industries Biotechnology, Health Care, Health and Wellness
Funding Stage Series Unknown
Social

Get notified when Boostimmune moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Boostimmune

Boostimmune is a biotech startup founded in 2021, dedicated to developing breakthrough therapies for cancer treatment by leveraging the power of the immune system. The company's slogan, "Developing breakthrough therapies to fight cancer by harnessing the power of the immune system through the dedication and expertise of an innovative team," underlines its commitment to innovation and addressing unmet needs in oncology. Boostimmune focuses on developing antibody-based therapies to modulate the immune system, with a mission to develop advanced anti-cancer therapies by enhancing the human immune system. The company operates in the Biotechnology and Health Care industries. The recent Venture Round investment at 01 January 2023 was led by Company K Partners, showcasing investor confidence in Boostimmune's vision and potential. With a dedicated team of industry experts, Boostimmune is well-positioned to overcome challenges in cancer treatment and make significant contributions to the field.

Taxonomy: Biotech, Cancer Treatment, Antibody-based Therapies, Immunotherapy, Oncology, Innovative Mindset, Industry Experts, Immune System Modulation, Cancer Therapy, Medical Innovation

Funding Rounds & Investors (3)

View All
Funding Stage Amount Investors Lead Investors Date
Venture Round •••••• 1
Investor
01 Jan 2023
Venture Round •••••• 1
Investor
22 Jun 2022
Non Equity Assistance •••••• 1 •••• •••• 14 Jun 2021

Boostimmune Alternatives & Competitors

Boostimmune vs

Developing immune therapies to activate the body's natural defense against cancer and related diseas...

Series Unknown
Biotechnology, Health and Wellness
Boostimmune vs

Seven and Eight Biopharmaceuticals Inc. is at the forefront of immuno-oncology innovations

2 employees
Biopharma, Biotechnology
Boostimmune vs
NextCure, Inc.
NextCure, Inc. United States

NextCure is a clinical-stage biopharmaceutical company committed to discovering and developing novel...

Post Ipo Equity
49 employees
Biopharma, Biotechnology
Also compare with: Boostimmune vs 3T Biosciences 3T Biosciences

FAQ About Boostimmune

Developing breakthrough therapies to fight cancer by harnessing the power of the immune system through the dedication and expertise of an innovative team.
Boostimmune was founded in 2021.
Boostimmune operates in the following industries: Biotechnology, Health Care, Health and Wellness.
Boostimmune has completed 3 funding rounds. The latest funding stage is Series Unknown.
Top alternatives and competitors to Boostimmune include IRX Therapeutics, Seven and Eight Biopharmaceuticals Inc., NextCure, Inc., Quentis Therapeutics, Tizona Therapeutics, Inc.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Boostimmune and IRX Therapeutics are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Boostimmune and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

One analytics cookie (Google Analytics). Cookie Policy